Murray Christopher K. 4
4 · Blueprint Medicines Corp · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Murray Christopher K.
SVP, Technical Operations
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+17,500→ 17,500 totalExercise: $43.15Exp: 2033-03-01→ Common Stock (17,500 underlying) - Award
Common Stock
2023-03-01+8,750→ 27,570 total
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of grant of 8,750 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan.
- [F2]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2023 and as to an additional 1/48th of the shares underlying the option each month thereafter.